ClinicalTrials.gov
public full text
Public Domain
A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants
This Phase 2b/3, randomized, double-blind, placebo-controlled, 2-part study will evaluate the efficacy, safety and tolerability of different dose regimens of SPG601 in adult male participants with Fragile X syndrome.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome#1111678
- The Impact of Fragile X Syndrome on Caregivers: A Systematic Review.#645522
- Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome#968795
- Post Isometric Relaxation Versus Post Facilitation Stretch Techniques in Chronic Low Back Pain#1057744
- Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD#841020
Record · ID 838452
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive